241 related articles for article (PubMed ID: 24793824)
1. A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in human brain tumors.
Bergamino M; Bonzano L; Levrero F; Mancardi GL; Roccatagliata L
Phys Med; 2014 Sep; 30(6):635-43. PubMed ID: 24793824
[TBL] [Abstract][Full Text] [Related]
2. Measuring the integrity of the human blood-brain barrier using magnetic resonance imaging.
Kassner A; Thornhill R
Methods Mol Biol; 2011; 686():229-45. PubMed ID: 21082374
[TBL] [Abstract][Full Text] [Related]
3. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
[TBL] [Abstract][Full Text] [Related]
4. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
Choyke PL; Dwyer AJ; Knopp MV
J Magn Reson Imaging; 2003 May; 17(5):509-20. PubMed ID: 12720260
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of IAUGC indices and two DCE-MRI pharmacokinetic parameters assessed by two different theoretical algorithms in patients with brain tumors.
Bergamino M; Barletta L; Castellan L; Saitta L; Mancardi GL; Roccatagliata L
Clin Imaging; 2014; 38(6):808-14. PubMed ID: 25115335
[TBL] [Abstract][Full Text] [Related]
6. Technical aspects of MR perfusion.
Sourbron S
Eur J Radiol; 2010 Dec; 76(3):304-13. PubMed ID: 20363574
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study.
van Vliet EA; Otte WM; Gorter JA; Dijkhuizen RM; Wadman WJ
Neurobiol Dis; 2014 Mar; 63():74-84. PubMed ID: 24321435
[TBL] [Abstract][Full Text] [Related]
8. Fundamentals of tracer kinetics for dynamic contrast-enhanced MRI.
Koh TS; Bisdas S; Koh DM; Thng CH
J Magn Reson Imaging; 2011 Dec; 34(6):1262-76. PubMed ID: 21972053
[TBL] [Abstract][Full Text] [Related]
9. Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.
Ingrisch M; Sourbron S
J Pharmacokinet Pharmacodyn; 2013 Jun; 40(3):281-300. PubMed ID: 23563847
[TBL] [Abstract][Full Text] [Related]
10. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
Hsu YH; Ferl GZ; Ng CM
Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
[TBL] [Abstract][Full Text] [Related]
11. Contrast enhanced MR imaging of female pelvic cancers: established methods and emerging applications.
Punwani S
Eur J Radiol; 2011 Apr; 78(1):2-11. PubMed ID: 20381276
[TBL] [Abstract][Full Text] [Related]
12. [Perfusion by magnetic resonance imaging: its physical foundations and clinical application].
Fayed-Miguel N; Castillo-Blandino J; Medrano-Lin J
Rev Neurol; 2010 Jan 1-15; 50(1):23-32. PubMed ID: 20073020
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
14. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
Rosen MA; Schnall MD
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
[TBL] [Abstract][Full Text] [Related]
16. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.
Ingrisch M; Sourbron S; Morhard D; Ertl-Wagner B; Kümpfel T; Hohlfeld R; Reiser M; Glaser C
Invest Radiol; 2012 Apr; 47(4):252-8. PubMed ID: 22373532
[TBL] [Abstract][Full Text] [Related]
17. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.
Heye AK; Culling RD; Valdés Hernández Mdel C; Thrippleton MJ; Wardlaw JM
Neuroimage Clin; 2014; 6():262-74. PubMed ID: 25379439
[TBL] [Abstract][Full Text] [Related]
18. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Contrast-Enhanced MRI in the Study of Brain Tumors. Comparison Between the Extended Tofts-Kety Model and a Phenomenological Universalities (PUN) Algorithm.
Bergamino M; Barletta L; Castellan L; Mancardi G; Roccatagliata L
J Digit Imaging; 2015 Dec; 28(6):748-54. PubMed ID: 25776769
[TBL] [Abstract][Full Text] [Related]
20. Boosting in Nonlinear Regression Models with an Application to DCE-MRI Data.
Feilke M; Bischl B; Schmid VJ; Gertheiss J
Methods Inf Med; 2016; 55(1):31-41. PubMed ID: 26577400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
